MD HB515 | 2026 | Regular Session
Status
Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on January 27 2026 - 25% progression
Action: 2026-02-13 - Hearing 2/24 at 1:00 p.m.
Pending: House Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 27 2026 - 25% progression
Action: 2026-02-13 - Hearing 2/24 at 1:00 p.m.
Pending: House Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring that the hospital representative on a local drug overdose fatality review team be a vice president, a chief medical officer, or an assistant medical officer at the hospital.
Title
Public Health - Local Drug Overdose Fatality Review Teams - Membership
Sponsors
| Del. Joe Vogel [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2026-02-13 | House | Hearing 2/24 at 1:00 p.m. |
| 2026-01-27 | House | First Reading Health |
Subjects
Committee Changes
Death
Drugs
Health
Health Occupations
Hospitals
Public Health
Review Boards
Substance Abuse
Death
Drugs
Health
Health Occupations
Hospitals
Public Health
Review Boards
Substance Abuse
Code Citations
| Chapter | Article | Section | Citation Type | Statute Text |
|---|---|---|---|---|
| Health - General | 5 | 901 | (n/a) | See Bill Text |
| Health - General | 5 | 902 | (n/a) | See Bill Text |
Maryland State Sources
| Type | Source |
|---|---|
| Summary | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0515?ys=2026RS |
| Text | https://mgaleg.maryland.gov/2026RS/bills/hb/hb0515f.pdf |
